1999
). Two bills currently in Congress will authorize substantial funding for AHCPR, change the name to either Agency for Health Research and Quality or Agency for Healthcare Research and Quality (AHRQ, pronounced "arc"), and specifically "prohibit the agency from mandating national standards of clinical practice or quality health care standards" (Reuters Health. 1999) .
Although the AHCPR has refrained from developing new standards of care, it has continued to produce evidence based medicine reports and has established evidence based practice centers with public and private partnerships. The reports summarize available scientific evidence about diagnosis and treatment of specific conditions and will continue to be a part of the mission of the to-be-authorized AHRQ.
The new reports, as well as the existing guidelines, represent a free and valuable resource for occupational health nurses. Findings of two of these evidence reports/technology assessments on rhinosinusitis and depression are described in this column, along with suggestions for their use by occupational health nurses. To produce the rhinosinusitis report (USDHHS. 1999a), a panel of technical experts identified the crucial questions to be answered. and a contractor systematically and critically reviewed the literature for answers. Meta analyses and subgroup analyses were performed to compare treatment outcomes and identify factors influencing variations. For the depression report, a similar process was employed, with formulation of 24 specific questions guided by two key principles: "...the potential to summarize new information not addressed in previous literature synthesis, and relevance to clinicians making treatment decisions and policymakers developing guidelines" (USDHHS, 1999b).
RHINOSINUSITIS
Diagnosis and Treatment of Acute Bacterial Rhinosinusitis, AHCPR Evidence Report/Technology Assessment No. 9 (USDHHS, 1999a) summarizes available scientific evidence about the diagnosis and treatment of uncomplicated, community acquired. acute bacterial rhinosinusitis in children and adults.
According to this report, acute rhinosinusitis is one of the most common infections in the United States. In 1992, Americans spent $200 million for prescription medications for rhinosinusitis and more than $2 billion for over the counter LINKING PRACTICE & RES EAR C H medications for rhinosinusitis. Many of these costs accrue to the workplace because health insurance pays for the prescription medication, and many worksites provide over the counter medications to workers free of charge.
Accurate diagnosis of the cause(s) of rhinosinusitis symptoms is important. Bacterial infections are potentially serious and should be treated with antibiotics. However, the overuse of antibiotics has negative ramifications for individuals and for society because it contributes to the development of drug resistant strains of bacteria. Other contributors to rhinosinusitis symptoms include viruses, fungi, allergies, anatomic abnormalities, systemic diseases, trauma, and noxious chemicals.
Five occupational health nurse to assess the worker's symptoms before providing over the counter medications for cold and sinus infection symptoms, in case antibiotic treatment may be warranted. In relation to antibiotics, amoxicillin was shown to be as effective as the newer and more expensive antibiotics.
DEPRESSION
Treatment of Depression-Newer Pharmacotherapies, AHCPR Evidence Report/Technology Assessment No.7 {summary] (USDHHS, 1999b) provides a comprehensive evaluation of the benefits and adverse effects of newer pharmacotherapies and herbal remedies. Older antidepressants and psychosocial therapies are considered only when they are compared directly to newer antidepressants. Efficacy of treatment in relation to reduction of symptoms, adherence, adverse effects, quality of life, functional status, and suicides are addressed in this report.
Depression is a significant problem costly to individuals, families, and society. According to this report, in 1990, costs for depression approached $44 billion (USDHHS, 1999b) . A 1993 report (Greenberg, 1993) allocated 55% of these costs to the workplace: $12.1 billion for excessive absenteeism and $11.7 billion for loss of productive capacity. The remainder of the nearly $44 billion was attributed to costs of direct treatment and mortality. Clearly, many of these costs are borne by the workplace through health insurance, lost time and productivity, and replacement workers.
Increasing attention has been directed toward recognizing and treating depression since the USD-HHS sponsored development of standard treatment guidelines. In 1993, AHCPR published a series of guidelines related to depression:
Depression in Primary Care: Vol. 1. Detection and Diagnosis (USDHHS, 1993a) ; Depression in Primary Care: Vol. 2. Treatment of Major Depression (USDHHS, 1993b) ; Depression in Primary Care: Clinical Practice Guideline: Depression in Primary Care: Detection, Diagnosis, and Treatment. Quick Reference Guide for Clinicians No. 5 (USD-HHS, 1993c) ; and a companion booklet, Depression in Primary Care: Clinical Practice Guideline: Depression is a Treatable illness: A Patient's Guide (USDHHS, 1993d) . The first two must be purchased, but the latter two are free. The clinician's guide (USDHHS, 1993c) , which summarizes diagnostic criteria, differential diagnosis, and treatments is a useful reference for occupational health nurses. The client's guide (USDHHS, 1999d) provides comprehensive information for any worker concerned about the problem of depression. Although these are not new (the clinician's guide was recommended in the 1996 column), they still are relevant and useful.
The new evidence report (1999b) evaluates the benefits and adverse effects of new pharmacotherapies and herbal treatments for depressive disorders. While occupational health nurses will not be prescribing antidepressants to workers, they may need to refer workers for treatment and field questions from workers about their therapy. Because workers also may self treat with herbal remedies, they may seek advice about the effects of these nonprescription remedies.
The studies reviewed found newer antidepressants were effective when compared with placebos, but few studies compared the newer antidepressants with the older antidepressants. These few studies found the newer drugs equally effective compared with the older ones. 588 studies evaluated combinations of new and old. In relation to herbal remedies, based on a relatively small number of trials, hypericum (St. John's wort) was more effective than a placebo for short term treatment of mild to moderately severe depressive disorders. Adverse effects occurred less often compared to treatment with antidepressant medications.
Both of the two new evidence reports described in this column are relevant for practicing occupational health nurses and are a valuable free resource. To obtain these reports and to identify others of potential interest, access the AHCPR website at http://www.abcpr.gov, or telephone the AHCPR Clearinghouse at 1-800-358-9295.
